A Study of EMB-02 in Participants With Advanced Solid Tumors

NCT04618393 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Stopped Company's resource optimization and product's development change

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: EMB-02

Sponsor

Shanghai EpimAb Biotherapeutics Co., Ltd.